RxDoctor Payments Data

Suraj Reddy, MD

Dermatology · Albuquerque, NMNPI 1740485275

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 139 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 23 manufacturers reported payments, led by AbbVie at 39.7% of the total. Reporting peaked in 2023 at $908 and has fallen 50.5% since, to $449 in 2025.

$2,966in general payments, 2019–2025

Across 139 payments — averaging $21.34 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$1K
  • Incyte Corporation$392
  • Novartis$327
  • Lilly USA, LLC$164
  • Amgen$150
  • Sanofi$119
  • plus $637 from 17 others

What the payments were for

  • Food & beverage$2,966100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$2,966 in reported general payments places this provider in the 70th percentile of 52 dermatology providers in New Mexico.

See all dermatology providers in New Mexico

Medicare billing

Part B allowed, 2024
$833,292
Medicare patients
1,534
Services billed
16,002

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Acitretin28$9,806
Fluorouracil88$4,315
Metronidazole100$3,601
Fluocinonide106$2,758
Clindamycin Phosphate99$2,681
Triamcinolone Acetonide341$2,143
Ketoconazole110$1,810
Calcipotriene11$1,480
Doxycycline Hyclate58$1,359
Clobetasol Propionate52$1,277
Hydrocortisone151$938
Clotrimazole-BetamethasoneClotrimazole/Betamethasone Dip49$763
Spironolactone37$677
Tretinoin12$613
Cephalexin71$461

Paid to pharmacies, not to this prescriber.

Other dermatology in Albuquerque

See the full list for New Mexico

Where these figures come from

Is this you, or does something look wrong? →